As described in a “Quality Improvement Success Story” published in this issue (1), Lauren Oshman and her colleagues implemented and studied the effect of an intervention called diabetes-focused visits (DFVs). These intensive, deliberately designed live office visits ultimately succeeded in reducing therapeutic inertia and helped patients get to glycemic goals. In reading the words written by these researchers and understanding what they left unsaid, it becomes evident that we have an opportunity to rethink our approach to diabetes and the role of “live” visits in the context of a rapidly evolving diabetes landscape in which the new focus must be on providing whole-person care and meeting people where they are.

This content is only available via PDF.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at